DUSP1 and metabolic dysfunction-associated steatotic liver disease: Our study demonstrates that LSG could downregulate the serum expression of miR-200c-3p and reduce the degradation of DUSP1 (Figures 2A–H) at the 3rd month postoperation in patients with NAFLD.